Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
Standard
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. / Michalick, Laura; Weidenfeld, Sarah; Grimmer, Benjamin; Fatykhova, Diana; Solymosi, Philip Daniel; Behrens, Felix; Dohmen, Melanie; Brack, Markus C; Schulz, Sabrina; Thomasch, Elisa; Simmons, Szandor; Müller-Redetzky, Holger; Suttorp, Norbert; Kurth, Florian; Neudecker, Jens; Toennies, Mario; Bauer, Torsten T; Eggeling, Stephan; Corman, Victor Max; Hocke, Andreas C; Witzenrath, Martin; Hippenstiel, Stefan; Kuebler, Wolfgang M.
in: EUR RESPIR J, Jahrgang 57, Nr. 3, 03.2021, S. 2002384.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
AU - Michalick, Laura
AU - Weidenfeld, Sarah
AU - Grimmer, Benjamin
AU - Fatykhova, Diana
AU - Solymosi, Philip Daniel
AU - Behrens, Felix
AU - Dohmen, Melanie
AU - Brack, Markus C
AU - Schulz, Sabrina
AU - Thomasch, Elisa
AU - Simmons, Szandor
AU - Müller-Redetzky, Holger
AU - Suttorp, Norbert
AU - Kurth, Florian
AU - Neudecker, Jens
AU - Toennies, Mario
AU - Bauer, Torsten T
AU - Eggeling, Stephan
AU - Corman, Victor Max
AU - Hocke, Andreas C
AU - Witzenrath, Martin
AU - Hippenstiel, Stefan
AU - Kuebler, Wolfgang M
PY - 2021/3
Y1 - 2021/3
N2 - The plasma of COVID-19 patients induces pulmonary microvascular barrier failure, which increases with disease severity. Here, a screening platform to test for plasma mediators and the therapeutic potential of barrier stabilising compounds is reported. https://bit.ly/3k4C0tB
AB - The plasma of COVID-19 patients induces pulmonary microvascular barrier failure, which increases with disease severity. Here, a screening platform to test for plasma mediators and the therapeutic potential of barrier stabilising compounds is reported. https://bit.ly/3k4C0tB
KW - Actins/metabolism
KW - Antigens, CD/metabolism
KW - COVID-19/blood
KW - Cadherins/metabolism
KW - Capillary Permeability
KW - Case-Control Studies
KW - Electric Impedance
KW - Endothelial Cells/metabolism
KW - Endothelium/metabolism
KW - Hospitalization
KW - Humans
KW - Lung/metabolism
KW - Microvessels/cytology
KW - Occludin/metabolism
KW - Plasma
KW - SARS-CoV-2
KW - Severity of Illness Index
U2 - 10.1183/13993003.02384-2020
DO - 10.1183/13993003.02384-2020
M3 - Other (editorial matter etc.)
C2 - 33154030
VL - 57
SP - 2002384
JO - EUR RESPIR J
JF - EUR RESPIR J
SN - 0903-1936
IS - 3
ER -